Pharma Aids Limited (DSE:PHARMAID)
536.60
+2.10 (0.39%)
At close: Mar 4, 2026
Pharma Aids Market Cap
Pharma Aids has a market cap or net worth of 1.67 billion as of March 4, 2026. Its market cap has decreased by -1.88% in one year.
Market Cap
1.67B
Enterprise Value
1.66B
Revenue
453.49M
Ranking
n/a
PE Ratio
24.84
Stock Price
536.60
Market Cap Chart
Since August 5, 2004, Pharma Aids's market cap has increased from 8.88M to 1.67B, an increase of 18,755.64%. That is a compound annual growth rate of 27.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.67B | 10.41% |
| Dec 30, 2025 | 1.51B | -15.56% |
| Dec 30, 2024 | 1.79B | -27.49% |
| Dec 28, 2023 | 2.47B | - |
| Dec 29, 2022 | 2.47B | 31.70% |
| Dec 30, 2021 | 1.87B | 26.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asiatic Laboratories | 7.44B |
| Orion Pharma | 7.23B |
| Navana Pharmaceuticals | 6.53B |
| Techno Drugs | 4.11B |
| Ambee Pharmaceuticals | 1.83B |
| Indo-Bangla Pharmaceuticals | 1.64B |
| Silco Pharmaceuticals | 1.48B |
| Libra Infusions | 1.47B |